CANCERS BRONCHIQUES A PETITES CELLULES
[3] Socinski & coll. Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naïve Patients With Extensive-Stage Small-Cell Lung Cancer. J Clin Oncol 27:4787-4792 (2009)
[4] Rossi & coll. Carboplatin or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer : The COCIS Meta-Analysis of Individual Patient Data. J Clin Oncol 30(14):1692-8 (2012)
[5] Pujol & coll. Etoposide Plus Cisplatin With or Without the Combination of 4_-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III
Randomized Study. J Natl Cancer Inst; 93(4):300-8 (2001)
[6] Von Pawel & coll. Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer. J Clin Oncol 17,658-67 (1999)
[7] Chen & coll. Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer. J Clin Oncol 27:1401-1404 (2009)
[8] Hermes & coll. Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial. J Clin Oncol 26:4261-4267 (2008)
Références bibliographiques:
[1] Fukuoka & coll. Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer. J Natl Cancer Inst 83:855–861 (1991)
[2] Eckardt & coll. Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment for Chemotherapy-Naive Patients With Extensive-Disease Small-Cell Lung Cancer. J
Clin Oncol 24, 2044-51 (2006)
THESAURUS REGIONAL BOURGOGNE : THORAX CBPC
Dernière mise à jour : mars 2014